2025-10-30 - Analysis Report
Okay, here's an analysis of Intuitive Surgical (ISRG) based on the data provided.

## Intuitive Surgical (ISRG) Analysis

**0. Executive Summary**

This report analyzes Intuitive Surgical Inc. (ISRG), a company specializing in robotic-assisted surgical systems. The analysis covers relative performance against the S&P 500 (VOO), recent stock movements, market risk indicators, analyst opinions, recent news, earnings, and key financial data. Overall, ISRG shows strong growth potential with some mixed signals in short-term performance.

**1. Relative Performance Against S&P 500 (VOO)**

*   **Ticker:** ISRG
*   **Company:** Intuitive Surgical Inc. (A company specializing in robotic-assisted surgical systems.)
*   **ISRG Cumulative Return:** 101.08%
*   **VOO Cumulative Return:** 104.04%
*   **Deviation:**
    *   Max Deviation: 100.5
    *   Min Deviation: -37.2
    *   Current Deviation: -26.1
    *   Relative Deviation: 8.1

**Analysis:** ISRG has underperformed the S&P 500 (VOO) in terms of cumulative return, with a current deviation of -2.96%. The relative deviation of 8.1 indicates that ISRG is positioned towards the lower end of its historical performance range relative to VOO.

**Alpha, Beta Analysis**

| Year       | CAGR   | MDD    | Alpha  | Beta  | Cap(B) |
|------------|--------|--------|--------|-------|--------|
| 2015-2017  | 68.0%  | 77.6%  | 40.0%  | -0.1  | 43.1   |
| 2016-2018  | 64.0%  | 72.2%  | 49.0%  | -0.0  | 56.6   |
| 2017-2019  | 54.0%  | 72.2%  | 31.0%  | 0.2   | 69.8   |
| 2018-2020  | -6.0%  | 80.4%  | -29.0% | 0.3   | 96.7   |
| 2019-2021  | 29.0%  | 80.4%  | -18.0% | 0.6   | 127.4  |
| 2020-2022  | -23.0% | 80.4%  | -22.0% | 1.2   | 94.1   |
| 2021-2023  | -17.0% | 77.5%  | -18.0% | 1.7   | 119.6  |
| 2022-2024  | 36.0%  | 77.5%  | 15.0%  | 1.7   | 185.0  |
| 2023-2025  | 63.0%  | 72.7%  | -5.0%  | 0.8   | 191.3  |

**Analysis:**
*   **CAGR (Compound Annual Growth Rate):** Varies significantly, ranging from negative values to high positive values, indicating fluctuating performance.
*   **MDD (Maximum Drawdown):** Consistently high MDD values suggest significant risk and volatility.
*   **Alpha:** Mostly positive in earlier years, but negative in recent years, indicating underperformance relative to its benchmark.
*   **Beta:** Generally low, but trending upward, suggesting increasing correlation with the market.
*   **Cap (B):** Market capitalization shows a growing trend, indicating overall company growth.

**2. Recent Stock Price Movements**

*   **Current Price:** 539.785
*   **Last Market Data:**
    *   Price: 539.92
    *   Previous Close: 545.39
    *   Change: -1.0
*   **5-Day Moving Average:** 543.175
*   **20-Day Moving Average:** 468.0148
*   **60-Day Moving Average:** 463.0034

**Analysis:** The current price is slightly below the previous close, indicating a minor recent dip. The 5-day moving average is above the 20-day and 60-day moving averages, suggesting a short-term upward trend. However, the price decreasing compared to the previous close suggests a potential minor correction. The fact that the price is well above the 20 and 60 day averages also indicates a recent sharp move up.

**3. Market Risk Indicators and Expected Return**

*   **Market Risk Indicator (MRI):** 0.9 (High Investment Recommended)
*   **RSI:** 77.83 (Approaching overbought territory)
*   **PPO:** 2.68
*   **Hybrid Signal:** Cash_0%_Buy 100% of cash (1 shares - Very Safe - MRI:0.90)
*   **Recent (20-day) Relative Deviation Change:** 5.2 (+) - Short-term increase
*   **Expected Return (%):** 151.1% (Long-term, relative to S&P 500)

**Analysis:**

*   **MRI:** Indicates a high investment recommendation.
*   **RSI:** Suggests the stock is approaching overbought conditions, which could indicate a potential pullback.
*   **PPO:** Indicates a positive trend.
*   **Hybrid Signal:** Strong buy signal.
*   **Recent Relative Deviation:** Indicates positive short-term momentum relative to the S&P 500.
*   **Expected Return:** Very high expected return, suggesting significant potential for outperformance over the long term. The price decline from 545.39 to 539.92 is a minor fluctuation, but it's important to monitor for further declines, given the high RSI.

**4. Recent News & Significant Events**

*   **[2025-10-29]** How The Latest Shifts Are Reshaping Intuitive Surgical's Long-Term Value Story (Simply Wall St.)
*   **[2025-10-29]** ISRG vs BSX: Comparing Q3 Earnings, Growth Strategies and Prospects (Zacks)
*   **[2025-10-29]** Bull of the Day: Intuitive Surgical (ISRG) (Zacks)
*   **[2025-10-29]** Intuitive Surgical and Oklo have been highlighted as Zacks Bull and Bear of the Day (Zacks)
*   **[2025-10-29]** Does Billionaire Philippe Laffont Know Something Wall Street Doesn't? His Hedge Fund Is Backing a Stock That Jumped 211% in Just 5 Days. (Motley Fool)
*   **[2025-10-28]** ISRG Rides on da Vinci 5 Momentum: Can This Growth Sustain? (Zacks)

**Analysis:** Recent news is predominantly positive, focusing on Intuitive Surgical's long-term value, strong Q3 earnings, favorable comparisons to competitors (BSX), and potential from the da Vinci 5 system. The article about Philippe Laffont's hedge fund backing a stock with a significant jump suggests potential speculative interest in the sector, though it's important to note that correlation does not equal causation.

**4-2. Analyst Opinions**

*   **Consensus:** Buy
*   **Mean Rating:** 1.94 (~Buy)
*   **Opinions:** 27
*   **Target Price:**
    *   Average: 594.29
    *   High: 700.00
    *   Low: 378.00
*Recent Rating Changes: Not available in provided data

**Analysis:** Analyst consensus is strongly positive with a Buy rating and a mean rating indicating general bullishness. The average target price of $594.29 suggests an upside potential from the current price.

**5. Recent Earnings Analysis**

| Date       | EPS   | Revenue      |
|------------|-------|--------------|
| 2025-10-22 | 1.98  | 2.51 B$      |
| 2025-07-23 | 1.84  | 2.44 B$      |
| 2025-04-23 | 1.95  | 2.25 B$      |
| 2024-10-18 | 1.59  | 2.04 B$      |
| 2025-10-22 | 1.59  | 2.04 B$      |

**Analysis:**
*   **EPS (Earnings Per Share):** Shows an increasing trend, indicating improved profitability.
*   **Revenue:** Similarly, revenue is growing, reflecting strong sales performance.
*Duplicated data:* There seem to be duplicated data entries

**6. Financial Information**

**Revenue and Profitability:**

| Quarter    | Revenue  | Profit Margin |
|------------|----------|---------------|
| 2025-06-30 | $2.44B   | 66.31%        |
| 2025-03-31 | $2.25B   | 64.69%        |
| 2024-12-31 | $2.41B   | 68.04%        |
| 2024-09-30 | $2.04B   | 67.41%        |
| 2024-06-30 | $2.01B   | 68.30%        |

**Capital and Profitability:**

| Quarter    | Equity    | ROE     |
|------------|-----------|---------|
| 2025-06-30 | $17.85B  | 3.69%   |
| 2025-03-31 | $17.11B  | 4.08%   |
| 2024-12-31 | $16.43B  | 4.17%   |
| 2024-09-30 | $15.58B  | 3.63%   |
| 2024-06-30 | $14.71B  | 3.58%   |

**Analysis:**

*   **Revenue and Profitability:** Consistent growth in revenue and strong profit margins indicate efficient operations and demand for ISRG's products/services.
*   **Capital and Profitability:** Growing equity suggests the company is retaining earnings and growing its asset base. ROE (Return on Equity) is relatively stable.

**7. Overall Analysis**

Intuitive Surgical (ISRG) presents a mixed but generally positive picture. While it has underperformed the S&P 500 recently, strong financial data including revenue, profit margin, and EPS growth, coupled with positive analyst sentiment and a high long-term expected return, suggest strong potential. The recent price pullback, despite being minor, coupled with the high RSI, warrants monitoring. Recent news highlights the company's strategic shifts and competitive strengths, particularly with the da Vinci 5. The high MRI suggests confidence in the investment, and the hybrid signal supports a buy recommendation. Overall, ISRG appears to be a promising long-term investment, but investors should be aware of potential short-term volatility and overbought conditions.
